Conversations on Twitter :
@FierceBiotech: Diamyd Medical sells off nerve-targeted delivery unit. More | Follow @FierceBiotech
@JohnCFierce: I'd like to see Lilly file an NDA on sola, see how regulators handle secondary analysis on data from 1 trial that couldn't be confirmed in 2nd. | Follow @JohnCFierce
@RyanMFierce: Top counterfeit drug events in 2012 report, shows this problem affects all of us. More | Follow @RyanMFierce
> Sanofi ($SNY) will collaborate with the Massachusetts General Hospital on a two-year translational medicine pact covering the development of new cancer drugs. Scientists from both will be spearheading efforts to obtain proof-of-concept data on drugs. Sanofi has been steadily building up its R&D presence in Boston. Release
> GlaxoSmithKline ($GSK) says it will team up with the nonprofit Aeras group to test an experimental TB vaccine. Story
> QRxPharma has executed a pact with Paladin Labs for the Canadian commercialization rights to MOXDUO, an immediate release formulation of morphine and oxycodone. Release
Pharma News
@FiercePharma: Will Optimer's plan to boost Dificid sales work? It's a volume-pricing move. More | Follow @FiercePharma
> Teva's 2nd-gen Copaxone makes the grade. Report
> No breakup for J&J? Goldman analyst says 'Sell'. Story
> Pfizer wraps up Celebrex suit in $164M settlement. News
> Should new drugs wear 'proceed with caution' labels? Article
@FierceMedDev: Check out our rundown of the year's biggest announced layoffs in the medical device world. More | Follow @FierceMedDev
@MarkHFierce: BD's CFO is leaving to pursue an "entrepreneurial opportunity." More | Follow @MarkHFierce
@DamianFierce: Biomet reduced its quarterly losses thanks to its $280M buy of DePuy's trauma unit. More | Follow @DamianFierce
> Hospital transparency may be driving down stent use. Report
> Researchers: Concealing a stent with antibodies will prevent clots. Story
> Study: FDA, CMS device approval times still run long. Item
Drug Delivery News
> NuPathe axes half its workforce, sells $28M of securities. Article
> Dissolving microneedles hit the sweet spot in diabetes. Item
> Diamyd Medical sells off nerve-targeted delivery unit. Story
> Smaller electric pulse hits the spot for DNA vaccines. Report
Biomarkers News
> Scratching a genetic itch in atopic dermatitis. More
> Biomarker panel spots the risk of Type 2 diabetes. Report
> Making a GENIE-us connection: Linking genes with diabetic kidney disease. Story
> Prostate cancer genetic barcodes predict aggressiveness. Article
And Finally… Investigators at the University of Illinois say they think they know why coffee has been linked to a reduction in risk for Alzheimer's, suggesting that the caffeine may be blocking inflammation that causes cognitive problems. Story